Beijing Hotgen Biotech Co Ltd (688068) - Total Liabilities

Latest as of September 2025: CN¥278.25 Million CNY ≈ $40.72 Million USD

Based on the latest financial reports, Beijing Hotgen Biotech Co Ltd (688068) has total liabilities worth CN¥278.25 Million CNY (≈ $40.72 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Beijing Hotgen Biotech Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Beijing Hotgen Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688068 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Beijing Hotgen Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Hotgen Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Wuxi Huadong Heavy Machinery Co Ltd SHE:002685	China	CN¥850.48 Million
Siam Global House Public Company Limited BK:GLOBAL	Thailand	฿14.40 Billion
TA-I Technology Co Ltd TW:2478	Taiwan	NT$3.02 Billion
Sansteel MinGuang Co Ltd Fujian SHE:002110	China	CN¥32.65 Billion
Zimplats Holdings Ltd AU:ZIM	Australia	AU$1.24 Billion
Upwork Inc NASDAQ:UPWK	USA	$669.26 Million
eXp World Holdings Inc NASDAQ:EXPI	USA	$223.48 Million
SINOTRANS LTD H YC 1 F:SIY	Germany	€38.08 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Beijing Hotgen Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Hotgen Biotech Co Ltd (688068) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.07	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Hotgen Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Hotgen Biotech Co Ltd (2016–2024)

The table below shows the annual total liabilities of Beijing Hotgen Biotech Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥251.77 Million ≈ $36.84 Million	+24.29%
2023-12-31	CN¥202.56 Million ≈ $29.64 Million	-62.87%
2022-12-31	CN¥545.59 Million ≈ $79.84 Million	-29.24%
2021-12-31	CN¥771.01 Million ≈ $112.82 Million	+395.12%
2020-12-31	CN¥155.72 Million ≈ $22.79 Million	+103.89%
2019-12-31	CN¥76.37 Million ≈ $11.18 Million	+34.75%
2018-12-31	CN¥56.68 Million ≈ $8.29 Million	+102.42%
2017-12-31	CN¥28.00 Million ≈ $4.10 Million	-3.91%
2016-12-31	CN¥29.14 Million ≈ $4.26 Million	--

About Beijing Hotgen Biotech Co Ltd

SHG:688068 China Biotechnology

Market Cap

$1.05 Billion

CN¥7.19 Billion CNY

Market Cap Rank

#8841 Global

#2212 in China

Share Price

CN¥77.53

Change (1 day)

+1.88%

52-Week Range

CN¥76.10 - CN¥250.80

All Time High

CN¥250.80